318 related articles for article (PubMed ID: 32849571)
1. Activation of Toll-Like Receptors Differentially Modulates Inflammation in the Human Reproductive Tract: Preliminary Findings.
Benjelloun F; Quillay H; Cannou C; Marlin R; Madec Y; Fernandez H; Chrétien F; Le Grand R; Barré-Sinoussi F; Nugeyre MT; Menu E
Front Immunol; 2020; 11():1655. PubMed ID: 32849571
[TBL] [Abstract][Full Text] [Related]
2. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN
Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462
[TBL] [Abstract][Full Text] [Related]
3. Effects of different TLR ligands on the expression of proinflammatory cytokines and avian β-defensins in the uterine and vaginal tissues of laying hens.
Abdel-Mageed AM; Isobe N; Yoshimura Y
Vet Immunol Immunopathol; 2014 Dec; 162(3-4):132-41. PubMed ID: 25467889
[TBL] [Abstract][Full Text] [Related]
4. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
5. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
6. Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates.
Kwissa M; Nakaya HI; Oluoch H; Pulendran B
Blood; 2012 Mar; 119(9):2044-55. PubMed ID: 22246032
[TBL] [Abstract][Full Text] [Related]
7. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse.
Soboll G; Schaefer TM; Wira CR
Am J Reprod Immunol; 2006 Jun; 55(6):434-46. PubMed ID: 16674601
[TBL] [Abstract][Full Text] [Related]
8. CpG oligodeoxynucleotide and double-stranded RNA synergize to enhance nitric oxide production and mRNA expression of inducible nitric oxide synthase, pro-inflammatory cytokines and chemokines in chicken monocytes.
He H; MacKinnon KM; Genovese KJ; Kogut MH
Innate Immun; 2011 Apr; 17(2):137-44. PubMed ID: 20083501
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome.
Manfrere KC; Torrealba MP; Miyashiro DR; Oliveira LM; de Carvalho GC; Lima JF; Branco AC; Pereira NZ; Pereira J; Sanches JA; Sato MN
Oncotarget; 2016 Nov; 7(46):74592-74601. PubMed ID: 27780938
[TBL] [Abstract][Full Text] [Related]
10. MHC expression and chemokine production in the murine vagina following intra-vaginal administration of ligands to toll-like receptors 3, 7 and 9.
Nurkkala M; Nordström I; Telemo E; Eriksson K
J Reprod Immunol; 2007 Apr; 73(2):148-157. PubMed ID: 17081619
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
Nagase H; Okugawa S; Ota Y; Yamaguchi M; Tomizawa H; Matsushima K; Ohta K; Yamamoto K; Hirai K
J Immunol; 2003 Oct; 171(8):3977-82. PubMed ID: 14530316
[TBL] [Abstract][Full Text] [Related]
14. Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model.
Ma Y; Poisson L; Sanchez-Schmitz G; Pawar S; Qu C; Randolph GJ; Warren WL; Mishkin EM; Higbee RG
Immunology; 2010 Jul; 130(3):374-87. PubMed ID: 20331478
[TBL] [Abstract][Full Text] [Related]
15. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
16. Decreased functional response to Toll like receptor ligands in patients with oral cancer.
Paleja B; Anand A; Chaukar D; D'Cruz A; Chiplunkar S
Hum Immunol; 2013 Aug; 74(8):927-36. PubMed ID: 23628388
[TBL] [Abstract][Full Text] [Related]
17. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090
[TBL] [Abstract][Full Text] [Related]
18. Co-stimulation with TLR7/8 and TLR9 agonists induce down-regulation of innate immune responses in sheep blood mononuclear and B cells.
Booth JS; Buza JJ; Potter A; Babiuk LA; Mutwiri GK
Dev Comp Immunol; 2010 May; 34(5):572-8. PubMed ID: 20051250
[TBL] [Abstract][Full Text] [Related]
19. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
20. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells.
Re F; Strominger JL
J Immunol; 2004 Dec; 173(12):7548-55. PubMed ID: 15585882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
